DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Brahmer J. et al.
Five-year follow-up from the CA209-003 study of Nivolumab in previously treated advanced non-small cell lung cancer: clinical characteristics of long-term survivors.
Presented at: 2017 AACR Annual Meeting; April 1-5, 2017;
Wahshington, DC: Abstract CT077
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.